MedPath

Antineoplaston A10

Generic Name
Antineoplaston A10
Drug Type
Small Molecule
Chemical Formula
C13H14N2O3
CAS Number
91531-30-5
Unique Ingredient Identifier
16VY3TM7ZO

Overview

Antineoplaston A10 has been used in trials studying the treatment of Sarcoma, Lymphoma, Lung Cancer, Liver Cancer, and Kidney Cancer, among others.

Background

Antineoplaston A10 has been used in trials studying the treatment of Sarcoma, Lymphoma, Lung Cancer, Liver Cancer, and Kidney Cancer, among others.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 3
Not yet recruiting
Posted: 2016/09/01
Sponsor:
Burzynski Research I...
Phase 2
Completed
Posted: 2003/01/27
Sponsor:
Burzynski Research I...
Phase 2
Withdrawn
Posted: 2003/01/27
Sponsor:
Burzynski Research I...

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath